C07C233/42

Inhibitors of histone deacetylase

The present invention relates to compounds of formula (I): ##STR00001##
or a pharmaceutically acceptable salt, hydrate, solvate, or prodrug thereof, wherein U, J, V, X, R.sup.2a, R.sup.2b, R.sup.2c, R.sup.5 and t are as described herein. The present invention relates generally to inhibitors of histone deacetylase and to methods of making and using them. These compounds are useful for promoting cognitive function and enhancing learning and memory formation. In addition, these compounds are useful for treating, alleviating, and/or preventing various conditions, including for example, neurological disorders, memory and cognitive function disorders/impairments, extinction learning disorders, fungal diseases and infections, inflammatory diseases, hematological diseases, and neoplastic diseases in humans and animals.

INHIBITORS OF HISTONE DEACETYLASE

The present invention relates to compounds of formula (I):

##STR00001##

or a pharmaceutically acceptable salt, hydrate, solvate, or prodrug thereof, wherein U, J, V, X, R.sup.2a, R.sup.2b, R.sup.2c, R.sup.5 and t are as described herein. The present invention relates generally to inhibitors of histone deacetylase and to methods of making and using them. These compounds are useful for promoting cognitive function and enhancing learning and memory formation. In addition, these compounds are useful for treating, alleviating, and/or preventing various conditions, including for example, neurological disorders, memory and cognitive function disorders/impairments, extinction learning disorders, fungal diseases and infections, inflammatory diseases, hematological diseases, and neoplastic diseases in humans and animals.

INHIBITORS OF HISTONE DEACETYLASE

The present invention relates to compounds of formula (I):

##STR00001##

or a pharmaceutically acceptable salt, hydrate, solvate, or prodrug thereof, wherein U, J, V, X, R.sup.2a, R.sup.2b, R.sup.2c, R.sup.5 and t are as described herein. The present invention relates generally to inhibitors of histone deacetylase and to methods of making and using them. These compounds are useful for promoting cognitive function and enhancing learning and memory formation. In addition, these compounds are useful for treating, alleviating, and/or preventing various conditions, including for example, neurological disorders, memory and cognitive function disorders/impairments, extinction learning disorders, fungal diseases and infections, inflammatory diseases, hematological diseases, and neoplastic diseases in humans and animals.

Peripheral alkyl and alkenyl chains extended benzene derivatives and pharmaceutical composition including the same

The compounds represented by Formula (I), which are peripheral alkyl and alkenyl chains extended benzene derivatives, are useful as dual autotaxin (ATX)/histone deacetylase (HD AC) inhibitors. These compounds may be included in a pharmaceutical composition along with a pharmaceutically acceptable carrier, and be used in a therapeutically effective amount for prophylaxis or treatment of various diseases and disorders. ##STR00001##

Peripheral alkyl and alkenyl chains extended benzene derivatives and pharmaceutical composition including the same

The compounds represented by Formula (I), which are peripheral alkyl and alkenyl chains extended benzene derivatives, are useful as dual autotaxin (ATX)/histone deacetylase (HD AC) inhibitors. These compounds may be included in a pharmaceutical composition along with a pharmaceutically acceptable carrier, and be used in a therapeutically effective amount for prophylaxis or treatment of various diseases and disorders. ##STR00001##

INHIBITORS OF AKR1C3 AND METHODS OF USE

Provided herein are compounds having a structure of formula (A), or pharmaceutically acceptable salts thereof, wherein R.sup.1, R.sup.2, R.sup.3, R.sup.4, R.sup.d and n are described herein. Also provided herein are compositions comprising compounds of Formula (A) and methods of using compound of Formula (A) in treating, inhibiting, and/or preventing disease such as cancers (e.g., prostate cancer).

##STR00001##

ORGANIC COMPOUND AND SYNTHESIS METHOD THEREOF, AND OPTOELECTRONIC DEVICE

An organic compound and synthesis method thereof, and an optoelectronic device. The organic compound includes a compound represented by the general formula (1):

##STR00001##

By disposing a film including the organic compound between a hole functional layer and an electron functional layer of an optoelectronic device, the luminous efficiency of the optoelectronic device may be improved, and the lifetime of the optoelectronic device may be prolonged.

ORGANIC COMPOUND AND SYNTHESIS METHOD THEREOF, AND OPTOELECTRONIC DEVICE

An organic compound and synthesis method thereof, and an optoelectronic device. The organic compound includes a compound represented by the general formula (1):

##STR00001##

By disposing a film including the organic compound between a hole functional layer and an electron functional layer of an optoelectronic device, the luminous efficiency of the optoelectronic device may be improved, and the lifetime of the optoelectronic device may be prolonged.